Mosby's 2014 Nursing Drug Reference (171 page)

BOOK: Mosby's 2014 Nursing Drug Reference
8.33Mb size Format: txt, pdf, ePub

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

febuxostat (Rx)

(feb-ux′oh-stat)

Uloric

Func. class.:
Antigout drug, antihyperuricemic

Chem. class.:
Xanthene oxidase inhibitor

ACTION:

Inhibits the enzyme xanthine oxidase, thereby reducing uric acid synthesis; more selective for xanthine oxidase than allopurinol

USES:

Chronic gout, hyperuricemia

CONTRAINDICATIONS:

Hypersensitivity

Precautions:
Pregnancy (C), breast-feeding, children, renal/hepatic/cardiac/neoplastic disease, stroke, MI, organ transplant, Lesch-Nyhan syndrome

DOSAGE AND ROUTES
Calculator

• Adult:
PO
40 mg daily, may increase to 80 mg daily if uric acid levels are >6 mg/dl after 2 wk of therapy

Available forms:
Tabs 40, 80 mg

Administer:
PO route

• 
Without regard to meals or antacids; may crush and add to foods or fluids

• 
A few days before antineoplastic therapy

SIDE EFFECTS

CNS:
Weakness, flushing

CV:
MI, atrial fibrillation, atrial flutter, AV block,
bradycardia, hypo/hypertension, palpitations,
sinus tachycardia, stroke,
angina

EENT:
Retinopathy, cataracts, epistaxis

GI:
Nausea, vomiting, anorexia
, constipation, diarrhea, dyspepsia, hematemesis, hepatitis, hepatomegaly, weight gain/loss, cholecystitis, cholelithiasis, melena

GU:
Renal failure, urinary urgency/frequency/incontinence, nephrolithiasis, hematuria

HEMA:
Thrombocytopenia, anemia, pancytopenia, leukopenia, bone marrow suppression

INTEG:
Rash

MISC:
Arthralgia, gout flare

PHARMACOKINETICS

Peak 1-1.5 hr; excreted in feces, urine; half-life 5-8 hr; protein binding 99.2%

INTERACTIONS

Increase:
toxicity—azaTHIOprine

Increase:
xanthine nephropathy, calculi—rasburicase, antineoplastics

Increase:
myelosuppression—mercaptopurine, theophylline

NURSING CONSIDERATIONS
Assess:

• 
Hyperuricemia:
uric acid levels q2wk; uric acid levels should be ≤6 mg/dl, flares may occur during first 6 wk of treatment

• 
CBC, AST, BUN, creatinine before starting treatment, periodically

• 
Renal disease:
I&O ratio; increase fluids to 2 L/day to prevent stone formation and toxicity

• 
For rash, hypersensitivity reactions; discontinue

• 
Gout:
joint pain, swelling; may use with NSAIDs for acute gouty attacks and gout flare (first 6 wk)

Evaluate:

• 
Therapeutic response: decreased pain in joints, decreased stone formation in kidneys, decreased uric acid levels

Teach patient/family:

• 
That tabs may be crushed

• 
To take as prescribed; if dose is missed, to take as soon as remembered; not to double dose

• 
To increase fluid intake to 2 L/day unless contraindicated

• 
To avoid alcohol, caffeine because they will increase uric acid levels

• 
To report cardiovascular events to prescriber immediately

• 
Gout:
That flares may occur during first 6 wk of treatment

Canada only   Side effects:
italics
= common;
bold
= life-threatening   
Nurse Alert

felodipine (Rx)

(fe-loe′-di-peen)

Plendil
, Renedil

Func. class.:
Antihypertensive, calcium channel blocker, antianginal

Chem. class.:
Dihydropyridine

Do not confuse:
Plendil
/pindolol/Pletal/PriLOSEC/Prinivil

ACTION:

Inhibits calcium ion influx across cell membrane, resulting in the inhibition of the excitation and contraction of vascular smooth muscle

USES:

Essential hypertension alone or with other antihypertensives

Unlabeled uses:
Hypertension in adolescents and children, angina pectoris; Prinzmetal’s angina (vasospastic)

CONTRAINDICATIONS:

Hypersensitivity to this product or dihydropyridines, sick sinus syndrome, 2nd- or 3rd-degree heart block, hypotension <90 mm Hg systolic

Precautions:
Pregnancy (C), breastfeeding, children, geriatric patients, CHF, hepatic injury, renal disease

DOSAGE AND ROUTES
Calculator

• Adult:
PO
5 mg/day initially; usual range 2.5-10 mg/day; max 10 mg/day; do not adjust dosage at intervals of <2 wk

• Geriatric:
PO
2.5 mg/day

Hepatic disease

• Adult:
PO
2.5-5 mg, max 10 mg/day

Hypertension in adolescent/child (unlabeled)

• Adolescent and child:
PO
2.5 mg initially, titrate upward, max 10 mg/day

Available forms:
Ext rel tabs 2.5, 5, 10 mg

Administer:
PO route

• 
Swallow whole; do not break, crush, or chew ext rel products

• 
Once daily with light meal; avoid grapefruit juice

SIDE EFFECTS

CNS:
Headache
, fatigue, drowsiness, dizziness, anxiety, depression, nervousness, insomnia, light-headedness, paresthesia, tinnitus, psychosis, somnolence, flushing

CV:
Dysrhythmia,
edema
,
CHF,
hypotension, palpitations,
MI, pulmonary edema,
tachycardia, syncope, AV block, angina

GI:
Nausea, vomiting, diarrhea, gastric upset, constipation, increased LFTs, dry mouth

GU:
Nocturia, polyuria

HEMA:
Anemia

INTEG:
Rash, pruritus

MISC:
Flushing, sexual difficulties, cough, nasal congestion, SOB, wheezing, epistaxis, respiratory infection, chest pain,
angioedema,
gingival hyperplasia

PHARMACOKINETICS

Peak plasma levels 2.5-5 hr, highly protein bound >99%, metabolized in liver, 0.5% excreted unchanged in urine, elimination half-life 11-16 hr

INTERACTIONS

Increase:
bradycardia, CHF—β-blockers, digoxin, phenytoin, disopyramide

Increase:
toxicity, hypotension—nitrates, alcohol, quiNIDine, zileuton, miconazole, diltiazem, delavirdine, quinupristin, dalfopristin, conivaptan, cycloSPORINE, cimetidine, clarithromycin, antiretroviral protease inhibitors, other antihypertensives, MAOIs, ketoconazole, erythromycin, itraconazole, propranolol

Decrease:
antihypertensive effects—NSAIDs, carBAMazepine, barbiturates, phenytoin

Drug/Herb

Increase:
antihypertensive effect—ginseng, ginkgo, hawthorn

Decrease:
antihypertensive effect—ephedra, St. John’s wort

Drug/Food

Increase:
felodipine level—grapefruit juice

NURSING CONSIDERATIONS
Assess:

• 
CHF:
I&O, weight daily; weight gain, crackles, dyspnea, edema, jugular venous distention

• 
Cardiac status: B/P, pulse, respiration; ECG periodically

• 
Angina pain:
location, duration, intensity; ameliorating, aggravating factors

Evaluate:

• 
Therapeutic response: decreased B/P, decreased anginal attacks, increased activity tolerance

Teach patient/family:

• 
To avoid hazardous activities until stabilized on product, dizziness no longer a problem

• 
To avoid OTC products, alcohol unless directed by prescriber; to limit caffeine consumption

• 
About the importance of complying with all areas of medical regimen: diet, exercise, stress reduction, product therapy

• 
That tablets may appear in stools but are insignificant

• 
To report dyspnea, palpitations, irregular heart beat, swelling of extremities, nausea, vomiting, severe dizziness, severe headache

• 
To change positions slowly to prevent orthostatic hypotension

• 
To obtain correct pulse; to contact prescriber if pulse <50 bpm

TREATMENT OF OVERDOSE:

Atropine for AV block, vasopressor for hypotension

Other books

License to Date by Susan Hatler
Dark Angel by Maguire, Eden
Recipe for Kisses by Michelle Major
Joy's Valentine by Destiny Wallace
Celestial Matters by Garfinkle, Richard
Mastiff by Pierce, Tamora
The Main Chance by Colin Forbes
Caribou Island by David Vann